Assay Detail
ADMET
CHEMBL969590
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Inhibition of human CYP1A2
3
Total Activities
3
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | ADMET |
| Organism | Homo sapiens |
| Confidence | 9 — Direct single protein target |
| Curated By | Autocuration |
Publication
Discovery of sodium 6-[(5-chloro-2-{[(4-chloro-2-fluorophenyl)methyl]oxy}phenyl)methyl]-2-pyridinecarboxylate (GSK269984A) an EP(1) receptor antagonist for the treatment of inflammatory pain.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 3 | 4.47 | 4.70 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL467114 | — | — | 1 | 4.70 |
| CHEMBL467720 | — | — | 1 | 4.50 |
| CHEMBL513491 | — | — | 1 | 4.21 |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL467114 | — | IC50 | = | 20000.0 | nM | 4.70 |
| CHEMBL467720 | — | IC50 | = | 32000.0 | nM | 4.50 |
| CHEMBL513491 | — | IC50 | = | 61000.0 | nM | 4.21 |